The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective
Binh Thang Tran, Kui Son Choi, Thanh Xuân Nguyễn, Dae Kyung Sohn, Sun‐Young Kim, Jae Kyung Suh, Van Sang Phan, Huu Tri Pham, Minh Hanh Nguyen, Thanh Bình Nguyễn, Huu Khoi Hoang, Thị Thanh Bình Nguyễn, Minh Tú Nguyễn, Jin‐Kyoung Oh
Abstract
The incidence and mortality of colorectal cancer (CRC) has increased rapidly in Vietnam, but the economic burden of this disease has never been estimated. We estimate the direct and indirect cost of CRC patients in Vietnam in 2018 using a prevalence-based approach and human capital method. The total economic cost of CRC was VND 3041.88 billion (~$132.9 million), representing 0.055% of the 2018 gross domestic product. Notably, indirect costs comprised 83.58 % of the total cost, 82.61% of which is future income loss, because CRC occurs during productive years. The economic burden of CRC in Vietnam is substantial. The medical cost for CRC diagnosis and treatment is higher for younger patients and for those in advanced stages. Strategies to decrease the economic burden of CRC at the patient and national level, such as screening programs, should be developed and implemented in Vietnam.